SCHEMBL1630458

SCHEMBL1630458

COc1cc(OC)c(-c2ccnn2-c2ccccc2Cl)cc1/C=C/c1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.44
MAPT P10636 3/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
NR3C2 P08235 2/20 0.37
NR1H2 P55055 1/20 0.36
MAPK14 Q16539 1/20 0.36
KCNN4 O15554 1/20 0.36
SLC16A3 O15427 1/20 0.34
SLC16A1 P53985 1/20 0.34
NFE2L2 Q16236 2/20 0.34
PDE10A Q9Y233 1/20 0.33
PTAFR P25105 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630462 1.00 HSP90AA1 (0.44) HSP90AA1MAPTKDM4ENPC1GAA
SCHEMBL1628547 0.88 CYP1A1 (0.41) HSP90AA1MAPTNR3C2NR1H2MAPK14
SCHEMBL1628551 0.88 CYP1A1 (0.41) HSP90AA1MAPTNR3C2NR1H2MAPK14
SCHEMBL1631539 0.86 CYP1A1 (0.43) HSP90AA1MAPTKDM4ENR3C2MAPK14
SCHEMBL1631540 0.86 CYP1A1 (0.43) HSP90AA1MAPTKDM4ENR3C2MAPK14
SCHEMBL1629067 0.86 NFE2L2 (0.42) HSP90AA1MAPTNR3C2MAPK14KCNN4
SCHEMBL1629065 0.86 NFE2L2 (0.42) HSP90AA1MAPTNR3C2MAPK14KCNN4
SCHEMBL1628895 0.84 NFE2L2 (0.42) HSP90AA1MAPTKDM4ENR3C2NR1H2
SCHEMBL1628894 0.84 NFE2L2 (0.42) HSP90AA1MAPTKDM4ENR3C2NR1H2
SCHEMBL1630297 0.84 HSP90AA1 (0.41) HSP90AA1MAPTKDM4ENPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885MAPT 2299/4885KDM4E 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.